[E-Daily Reporter Choi Jeong-hee ] The investigation team at the Seoul Regional Tax Office conducted a tax audit of a pharmaceutical wholesaler starting in August 2024. The company is a wholesale and retail firm that supplies prescription drugs and medical devices to hospitals and pharmacies.
During the tax audit, one document caught the attention of the investigation team.
“Profit and Loss Analysis by Sales Channel—Affiliated Business Partners”
It was a file that singled out sales from 15 specific hospitals and their nearby pharmacies—out of more than 400 business partners. It meticulously detailed how much profit each hospital generated for the company.
But something seemed off. It turned out that the spouses and children of the directors of these 15 hospitals were shareholders of the company. Cash was deposited into their bank accounts every year in the form of dividends.
The investigation team concluded:
“These aren’t dividends. They’re kickbacks paid in exchange for purchasing the drugs.”
The National Tax Service classified the dividends as rebates (other income) received by nine doctors and notified the company to withhold the corresponding taxes on their behalf (Notice of Income Amount Adjustment). The intent was to have the company withhold taxes on the dividends.
Two years later, the Tax Tribunal reached the exact opposite conclusion.
80% of the shareholders are family members of hospital directors with whom the company does business
Mr. Kim, the CEO of this company, started a small wholesale business in 2001 supplying specialty pharmaceuticals and medical devices to hospitals and pharmacies. In 2007, he incorporated the business and expanded its operations.
Starting in 2010, Mr. Kim began selling company shares to the directors of client hospitals and their children. By the end of 2010, Mr. Kim’s stake had shrunk to just 20%. The remaining 80% was held by the directors of client hospitals, their children, and their spouses. Coincidentally, the company’s revenue roughly tripled the following year and continued to grow steadily thereafter.
A review of the shareholder list at the end of 2022 revealed that 57 spouses and children of doctors from partner hospitals were listed. These 57 individuals held approximately 77.5% of the shares. There were 15 hospitals linked to them.
Since 2013, the company has paid out nearly half (an average of 49.6%) of its net income as dividends every year. This is two to three times the average for publicly traded companies.
The scheme suspected by the National Tax Service was simple.
“Doctors prescribe this company’s drugs, the company makes money, and a portion of those profits is paid to the doctors’ families under the guise of dividends.”
Since it is difficult to give money directly to doctors due to the Medical Service Act, the NTS determined that the company had made the doctors’ family members shareholders and disguised the payments as dividends.
The National Tax Service cited several pieces of evidence. It noted that the hospital director’s family members purchased shares in the company around the time the hospital began doing business with it, and that they sold those shares without exception once the transactions concluded. The agency also observed that the timing of the sales was predetermined: before the record date for the shareholder registry in the year following the fiscal year in which the transactions ended.
Changes in shareholding percentages were also raised as an issue. According to the National Tax Service, at one hospital where the profits retained by the company had decreased since 2021, the shareholding dropped by half, from 5% to 2.5%. Conversely, the National Tax Service found that the company had been increasing its stake in hospitals that generated significant profits. According to the agency’s calculations, 20% to 50% of the profits generated by doctors’ prescriptions in 2021 were distributed as dividends.
One shareholder stated during the tax audit that the CEO had introduced people to buy and sell shares. The National Tax Service also pointed out that the transaction prices for the shares were lower than their assessed values under tax law. In 2023, the company established another entity with a similar structure. The shareholder positions in the new company were filled by the minor children of hospital directors from partner institutions, among others.
“Rebates vs. Dividends Paid to Shareholders”
However, Mr. Kim, the company’s CEO, made a different claim.
A rebate is money returned to a doctor from a portion of the profits earned from selling medication. Therefore, hospitals that prescribed more medication should receive more, while those that prescribed less should receive less. Mr. Kim’s logic was that, at the very least, the amount returned could not exceed the profits earned from selling the medication.
However, the actual dividend breakdown told a different story.
Let’s assume a hospital purchased medicine from the company for 100 won. One hospital director’s family received 4 won in dividends, while another’s received 148 won. In other words, there were cases where the dividend amount exceeded the price the hospital paid for the medicine.
How could this have been possible?
Mr. Kim’s answer was simple: it was because these were dividends, not rebates, to begin with. Dividends are paid based on the number of shares held, not on how much medicine was sold.
Shareholders purchased the shares with their own money, and when they received that money from their parents or spouses, they paid gift tax. There were even hospitals that didn’t buy shares until as long as 5 years and 10 months after beginning business with the company.
Mr. Kim also argued that, regarding a shareholder’s statement that he had introduced people to buy and sell shares, he had merely acted as an intermediary. He stated that the ledgers the National Tax Service initially focused on—specifically, the profit analysis by client—were standard practice for any wholesale company.
He also pointed out that the National Tax Service’s logic was inconsistent. During the objection phase, the agency claimed, “We imposed the tax because the dividends themselves were invalid, not because we applied the substance-over-form principle,” but during the tax appeal process, it cited the “substance-over-form principle” as the basis for taxation.
More than half of the revenue was generated from sources other than the shareholder’s hospital
In late October 2026, approximately two years after the tax audit began, the Tax Tribunal (Case No. 2025Seo3143) ruled in Mr. Kim’s favor.
The decision ordered the complete revocation of the National Tax Service’s notice of income adjustment.
The Tribunal stated that for the National Tax Service to deem these transactions “fictitious,” it must prove that they were fabricated by the company, the hospital director, and their families to evade taxes.
If the dividends were rebates, there would need to be a clear causal relationship—such as “the doctor prescribed medication, so money was paid”—but this was not the case. Dividends were distributed based on the number of shares held, regardless of prescription volume or sales. In particular, more than half (58%) of the company’s sales and gross profit came from general business partners, not from hospitals or nearby pharmacies linked to the shareholders.
The Tribunal ruled that, even though there was no evidence the company had funneled profits exclusively to specific shareholders, the National Tax Service’s conclusion that the dividends constituted kickbacks solely because the shareholders were doctors’ family members exceeded the scope of the substance-over-form principle. In other words, the National Tax Service had interpreted the substance-over-form principle too broadly.
※ This article reconstructs the sequence of events based on the Tax Tribunal’s decision. Since the real names of the individuals involved and some specific monetary amounts were not disclosed in the Tribunal’s decision, the content is based solely on verified facts. However, certain elements—such as the individuals’ surnames and the terms used to address spouses—were arbitrarily assigned for readability, as these details were not specified in the actual decision.